When a global pandemic hits, it might be safe to hope for a reprieve from additional steps before claims are approved within healthcare systems and large organizations alike. Most physicians in the US, however, had no such luck. According to a recent survey conducted by the American Medical Association (AMA), 94% of physicians reported care delays due to waiting for health insurers to authorize vital care. Of 1000 practicing physicians surveyed in December 2020, 30% reported that prior authorization (PA) requirements led to serious negative repercussions, including hospitalization, life-threatening events, and disability or permanent bodily damage.
Prior authorization reform is at the top of the AMA’s to-do list when it comes to advancing patient care. Organizations representing pharmacists, medical groups, hospitals, health plans, and the AMA itself joined forces in January 2018 to sign a commitment statement aimed at improving 5 key areas of the PA process. Since then, not much progress has been made towards implementing change.
How CMT Can Help
CMT Solutions can help with these requirements by performing physician-directed prior authorizations for laboratory tests. We have a vast network of more than 35,000 physicians – our dedicated physician account management team can enroll your physician office quickly and efficiently, ensuring patients get the necessary testing and care.
Read the full press release from the AMA here.
CMT offers combined expertise in laboratory, technology solutions, and HUB services to help both patients and physicians. It is the market leader in molecular diagnostic patient access, offering prior authorizations, benefits investigation, notifications, genetic counseling, and more.